Rupintrivir
Rupintrivir (AG-7088, Rupinavir) is a peptidomimetic antiviral drug which acts as a 3C and 3CL protease inhibitor. It was developed for the treatment of rhinoviruses, and has subsequently been investigated for the treatment of other viral diseases including those caused by picornaviruses, norovirus, and coronaviruses, such as SARS and COVID-19.
Q2069797
peptidomimetic
Concept
Q846227
antiviral
Concept
Q12779942
3C
MISC
Q12856813
3CL
Concept
Q55761529
protease inhibitor
Concept
Q1351647
rhinovirus
Concept
Q936600
picornavirus
Concept
Q1142751
norovirus
Concept
Q89469904
coronavirus
Concept
Q103177
SARS
Concept
Q84263196
COVID-19
Concept
Q27095569
Rupintrivir
UNK
-7088^^http://www.w3.org/2001/XMLSchema#decimal
-7088
NUMBER
+3^^http://www.w3.org/2001/XMLSchema#decimal
3
NUMBER
+3^^http://www.w3.org/2001/XMLSchema#decimal
3
NUMBER
-19^^http://www.w3.org/2001/XMLSchema#decimal
-19
NUMBER
subclass of
different from